Withdrawing Amantadine in Dyskinetic Patients with Parkinson Disease
Neurol 82:300-307, Ory-Magne, F.,et al, 2014
Evidence-Based Guideline: Pharmacologic Treatment of Chorea in Huntington Disease
Neurol 79:597-603, Armstrong, M.J. & Miyasaki, J.M., 2012
Treatments of Parkinson Disease
Arch Neurol 60:1680-1684, Shults,C.W., 2003
Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995
Fatigue Therapy in Multiple Sclerosis:A Double-blind, Randomized, Parallel Trial of Amantadine, Pemoline & Placebo
Neurol 45:1956-1961, Krupp,L.B.,et al, 1995
Effect of Add-on Amantadine Therapy for Refractory Absence epilepsy
J Pediatr 121:819-821, Shahar,E.M.&Brand,N., 1992
Amantadine Treatment of Fatigue Associated with Multiple Sclerosis
Arch Neurol 46:676-680, Cohen,R.A.&Fisher,M., 1989
Persistent Hiccup Cured by Amantadine
NEJM 318:711, Askenasy,J.J.M.,et al, 1988
The Treatment of Friedreich's Ataxia with Amantadine Hydrochloride
Neurol 38:1478-1480, Peterson,P.L.,et al, 1988
Amantadine, Fatigue, and Multiple Sclerosis
Arch Neurol 45:1104-1106, Rosenberg,G.A.&Appenzeller,O., 1988
Neuroleptic Malignant Syndrome
NEJM 313:163-166, Guze,B.H.,et al, 1985
Creutzfeldt-Jakob Disease Treated with Amantadine
JNNP 42:960-961, Sanders,W.L., 1979
Drug Therapy of Parkinsonism
NEJM 295:814, Bianchine,J.R., 1976